Big Pharma Is Flooding Puerto Rico With Toxic Waste

Dead livestock, cancer, arsenic in your water—that’ll be $100 billion in tax breaks, please.

Vitranc/Getty

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

In Puerto Rico, cheap labor and generous tax breaks—since 2017, more than $100 billion worth—have made US-based pharmaceutical firms the biggest economic players in town. Drug manufacturers have brought in tens of thousands of jobs, albeit with a tax-break price tag of more than $1 million each. But a new report by the nonprofit Center for Popular Democracy and advocacy group Hedge Clippers suggests that Big Pharma’s footprint on the island has come with other serious costs: illegal dumping of toxic waste, pollution and depletion of groundwater, and violations of other vital Environmental Protection Agency regulations. The report, released Tuesday, paints a disturbing picture, holding US pharmaceutical corporations at least partially responsible for Puerto Rico’s disproportionately high rates of asthma and cancer. The sum of its findings: a pattern of environmental racism resulting in more than a dozen Big Pharma–related Superfund sites, with the complicity of federal and local authorities. 

Puerto Rico is home to some 500 EPA-designated, toxin-packed Superfund sites, half of which were “active” as of July, meaning they pose an ongoing risk to the surrounding communities and ecosystems. Eighteen of its active sites are on the EPA’s “national priorities list,” which tracks areas most likely to release harmful compounds; of those, 15 are linked to the pharmaceutical industry. And Superfund sites don’t include every area where industries have improperly disposed of hazardous waste—just the most serious health and environmental threats.

The island’s Big Pharma waste sites belong to some of the world’s largest and best-known pharmaceutical companies, including Pfizer, Abbott Chemical, Johnson and Johnson, Roche, and GlaxoSmithKline. One-third of the pharmaceutical and medical manufacturers operating in Puerto Rico have been cited by the EPA for environmental malfeasance in just the last three years, meaning they flouted regulations while Puerto Ricans reeled from the deadly effects of Hurricane Maria. Of those violations, half took place within three miles of low-income neighborhoods of color.

One Pfizer facility, for instance, has been in continuous violation since 2020 of federal limits on lead and copper in drinking water. An Amgen facility has repeatedly failed to report discharged chemicals, and neglected to monitor its water treatment system for pathogens in 2021. The surrounding rivers are polluted with ammonia, arsenic, phosphorus, and selenium, which the EPA says is likely linked to Amgen and other industrial waste producers.

Most shocking, perhaps, is the extent to which Big Pharma has polluted the island’s groundwater. Barceloneta, a town on the northern coast that once contained 60 percent of Puerto Rico’s groundwater, has also been host to more than half a dozen pharmaceutical companies. By 1987, 41 percent of drinking water wells in the North Coast region were closed due to contamination. Some pollution in the area is ongoing, but much contamination also remains from earlier decades.

Abbott Laboratories, an Illinois-based medical conglomerate that manufactures supplies from COVID-19 tests to infant formula, was one of multiple companies that allowed chlorinated hydrocarbons—chemicals linked to cancer and immunosuppression—to spill out of underground tanks, according to the EPA. Those storage sites are often located near public drinking wells, and their toxins can’t be filtered out by the porous limestone aquifers used to move drinking water. Via sinkholes and sprinklers, the compounds contaminate the groundwater that most Puerto Rican farmers use to irrigate their crops. Other companies have been caught dumping pharmaceutical waste into the region’s Manatí River, killing fish hauls and livestock, giving fishermen sores, and causing the development of unwanted vegetation and odors. Although those violations were first caught decades ago, the region’s water remains unsafe.

Pharmaceuticals and medical manufacturing are Puerto Rico’s biggest industries, accounting for just under a third of the island’s 2017 GDP. It’s a sector that used to be even bigger, thanks to plush tax loopholes for businesses in US overseas territories, and local laws that for twenty years allowed drug companies to enjoy a corporate tax rate of zero. The COVID-19 pandemic, and anxieties about China’s economic growth, have renewed conversations about once again expanding drug manufacturing in the United States’ main Caribbean colony. It’s an idea supported by leaders like former Puerto Rico Gov. Aníbal Acevedo Vilá, as well as ex–Trump administration officials.

But mainland pharmaceutical giants, as the report shows, are major contributors to the atrocious water quality that millions of Puerto Ricans deal with daily. Recent data is limited, but a report from the National Resources Defense Council found that, as of 2015, more than 99.5 percent of Puerto Ricans relied on water that failed to meet Safe Water Drinking Act standards. PRASA, the island’s water utility, has a history of being fined by the EPA for failing to comply with Clean Water Act safety requirements.

Now, the climate crisis is making the water situation even more dire: after Hurricane Maria, residents of the town of Dorado were forced to drink well water from a Superfund site. In that case, the pollution wasn’t conclusively tied to a pharmaceutical company—but ones nearby had been the subjects of EPA enforcement actions for multiple infractions. Hurricanes and other disasters, more severe and unpredictable as a result of climate change, also always threaten to spread contamination from polluted sites.

The investigation follows previous exposés by the Center for Popular Democracy and Hedge Clippers that revealed workplace abuse and pervasive low wages in Puerto Rico’s pharmaceutical sector. As many as 90,000 Puerto Ricans work to make some of the most important life-saving drugs on the planet—which come, as these reports make clear, at high cost to their own lives.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate